Patient outcome after complete surgery for retroperitoneal sarcoma

Carlo Riccardo Rossi, Andrea Varotto, Sandro Pasquali, Luca Giovanni Campana, Simone Mocellin, Antonio Sommariva, Maria Cristina Montesco, Marco Rastrelli, Antonella Vecchiato, Pierluigi Pilati, Donato Nitti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Aggressive surgery has been suggested for improving local tumor control in patients with retroperitoneal sarcoma (RS). This study aimed at investigating local disease-free and overall survival after complete surgery, in patients with RS. Patients and Methods: Retrospective data of patients submitted to complete surgery for RS were extracted from a prospectively- maintained database. Results: Forty-three out of 78 patients (55%) presented with primary RS. Infiltrated organs were resected in 42 patients (54%). Patients presenting with recurrent (hazard ratio (HR)=5.57, p=0.002) and high-grade (HR 3.47, p=0.041) tumors were at higher risk of local recurrence. Microscopically-involved tumor resection margins (HR=3.47, p=0.04) and recurrent tumor at presentation (HR=2.49, p=0.008) were independent predictors of poor survival. Conclusion: Patients presenting with primary RS had longer local disease-free survival and overall survival than those with recurrent tumor after complete surgery. Complete surgery remains the standard-of-care for patients with primary RS.

Original languageEnglish
Pages (from-to)4081-4088
Number of pages8
JournalAnticancer Research
Volume33
Issue number9
Publication statusPublished - Sep 2013

Fingerprint

Sarcoma
Neoplasms
Disease-Free Survival
Survival
Standard of Care
Databases
Recurrence

Keywords

  • Disease-free survival
  • Overall survival
  • Retroperitoneal sarcoma
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Rossi, C. R., Varotto, A., Pasquali, S., Campana, L. G., Mocellin, S., Sommariva, A., ... Nitti, D. (2013). Patient outcome after complete surgery for retroperitoneal sarcoma. Anticancer Research, 33(9), 4081-4088.

Patient outcome after complete surgery for retroperitoneal sarcoma. / Rossi, Carlo Riccardo; Varotto, Andrea; Pasquali, Sandro; Campana, Luca Giovanni; Mocellin, Simone; Sommariva, Antonio; Montesco, Maria Cristina; Rastrelli, Marco; Vecchiato, Antonella; Pilati, Pierluigi; Nitti, Donato.

In: Anticancer Research, Vol. 33, No. 9, 09.2013, p. 4081-4088.

Research output: Contribution to journalArticle

@article{408c44cb11f7451eab8d89d39c07a8e0,
title = "Patient outcome after complete surgery for retroperitoneal sarcoma",
abstract = "Background: Aggressive surgery has been suggested for improving local tumor control in patients with retroperitoneal sarcoma (RS). This study aimed at investigating local disease-free and overall survival after complete surgery, in patients with RS. Patients and Methods: Retrospective data of patients submitted to complete surgery for RS were extracted from a prospectively- maintained database. Results: Forty-three out of 78 patients (55{\%}) presented with primary RS. Infiltrated organs were resected in 42 patients (54{\%}). Patients presenting with recurrent (hazard ratio (HR)=5.57, p=0.002) and high-grade (HR 3.47, p=0.041) tumors were at higher risk of local recurrence. Microscopically-involved tumor resection margins (HR=3.47, p=0.04) and recurrent tumor at presentation (HR=2.49, p=0.008) were independent predictors of poor survival. Conclusion: Patients presenting with primary RS had longer local disease-free survival and overall survival than those with recurrent tumor after complete surgery. Complete surgery remains the standard-of-care for patients with primary RS.",
keywords = "Disease-free survival, Overall survival, Retroperitoneal sarcoma, Soft tissue sarcoma",
author = "Rossi, {Carlo Riccardo} and Andrea Varotto and Sandro Pasquali and Campana, {Luca Giovanni} and Simone Mocellin and Antonio Sommariva and Montesco, {Maria Cristina} and Marco Rastrelli and Antonella Vecchiato and Pierluigi Pilati and Donato Nitti",
year = "2013",
month = "9",
language = "English",
volume = "33",
pages = "4081--4088",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

TY - JOUR

T1 - Patient outcome after complete surgery for retroperitoneal sarcoma

AU - Rossi, Carlo Riccardo

AU - Varotto, Andrea

AU - Pasquali, Sandro

AU - Campana, Luca Giovanni

AU - Mocellin, Simone

AU - Sommariva, Antonio

AU - Montesco, Maria Cristina

AU - Rastrelli, Marco

AU - Vecchiato, Antonella

AU - Pilati, Pierluigi

AU - Nitti, Donato

PY - 2013/9

Y1 - 2013/9

N2 - Background: Aggressive surgery has been suggested for improving local tumor control in patients with retroperitoneal sarcoma (RS). This study aimed at investigating local disease-free and overall survival after complete surgery, in patients with RS. Patients and Methods: Retrospective data of patients submitted to complete surgery for RS were extracted from a prospectively- maintained database. Results: Forty-three out of 78 patients (55%) presented with primary RS. Infiltrated organs were resected in 42 patients (54%). Patients presenting with recurrent (hazard ratio (HR)=5.57, p=0.002) and high-grade (HR 3.47, p=0.041) tumors were at higher risk of local recurrence. Microscopically-involved tumor resection margins (HR=3.47, p=0.04) and recurrent tumor at presentation (HR=2.49, p=0.008) were independent predictors of poor survival. Conclusion: Patients presenting with primary RS had longer local disease-free survival and overall survival than those with recurrent tumor after complete surgery. Complete surgery remains the standard-of-care for patients with primary RS.

AB - Background: Aggressive surgery has been suggested for improving local tumor control in patients with retroperitoneal sarcoma (RS). This study aimed at investigating local disease-free and overall survival after complete surgery, in patients with RS. Patients and Methods: Retrospective data of patients submitted to complete surgery for RS were extracted from a prospectively- maintained database. Results: Forty-three out of 78 patients (55%) presented with primary RS. Infiltrated organs were resected in 42 patients (54%). Patients presenting with recurrent (hazard ratio (HR)=5.57, p=0.002) and high-grade (HR 3.47, p=0.041) tumors were at higher risk of local recurrence. Microscopically-involved tumor resection margins (HR=3.47, p=0.04) and recurrent tumor at presentation (HR=2.49, p=0.008) were independent predictors of poor survival. Conclusion: Patients presenting with primary RS had longer local disease-free survival and overall survival than those with recurrent tumor after complete surgery. Complete surgery remains the standard-of-care for patients with primary RS.

KW - Disease-free survival

KW - Overall survival

KW - Retroperitoneal sarcoma

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84885013136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885013136&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 4081

EP - 4088

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -